Vinorelbine | advanced breast cancer (metastatic), in all type of patients | vs | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients Trial | Studied treatment | Control | Patients |
---|
Meier, 2008 | | | | Martin, 2007 | | | | Kim, 2006 | | | | Norris, 2000 | | | | Ejlertsen, 2004 | | | | Pajk, 2007 | | | | Venturino, 2000 | | | | Frasci, 2000 | | | | Verma, 2007 | | | |
|